Department of Infectious Diseases, Fatemieh Hospital, Islamic Republic of lran.
East Mediterr Health J. 2010 Apr;16(4):371-4.
This study in the Islamic Republic of Iran aimed to determine whether metoclopramide can prevent nosocomial pneumonia in the intensive care unit (ICU). Of 220 patients admitted to the surgical ICU who had a nasogastric tube for more than 24 hours, 68 case patients received oral metoclopramide (10 mg every 8 hours) and 152 control patients did not. Similar proportions of cases and controls developed nosocomial pneumonia (33.8% versus 33.6%). Endotracheal intubation was a risk factor for nosocomial pneumonia (odds ratio 7.70). There were no significant differences between groups in mortality rate or time of onset of nosocomial pneumonia. Metoclopramide appears to have no effect on the development of nosocomial pneumonia with nasogastric feeding.
本研究在伊朗伊斯兰共和国进行,旨在确定甲氧氯普胺是否可以预防重症监护病房(ICU)中的医院获得性肺炎。在因外科原因入住 ICU 并留置胃管超过 24 小时的 220 名患者中,68 例病例患者接受了甲氧氯普胺(每 8 小时口服 10mg)治疗,152 例对照患者未接受治疗。病例组和对照组发生医院获得性肺炎的比例相似(33.8% 对 33.6%)。气管插管是医院获得性肺炎的一个危险因素(比值比 7.70)。两组之间的死亡率或医院获得性肺炎的发病时间无显著差异。甲氧氯普胺似乎对胃管喂养相关的医院获得性肺炎的发展没有影响。